Age3 yrs
Real estate2 parcels · 1,234 m²
Summary
Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of AREDENTAL is 0.5% (low). The 2024 annual accounts show negative equity (€-61k) and a net result of €-103k. Its solvency ranks better than 5% of 6573 sector peers (fiscal year 2024). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 2 annual accounts.
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone0.5%
Low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector
−Young company
+Higher-failure-rate region
+
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Signals
1 signal · with evidenceNegative equity
Equity is negative for financial year 2024: liabilities exceed assets. This is the trigger point of the alarm-bell procedure (Belgian CAC).
View the annual accounts Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.
Trust signals
2 signalsMore than 3 years active
Founded in 2022, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No administrative flags
Financials
TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€-103k
Working capital€-232k-72.7%
Annual accounts & ratios
Source: NBB · 2024Annual accounts filed on 22-01-2026 with the NBB · fiscal year 2024 · micro
Sector comparison
Fiscal year 2024 · NACE 86, Human health · compared within the same schema type (micro schema)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | -5.2% | 66.7% | |
| Net result | €-103k | €46k | |
| Equity | €-61k | €79k | |
| Gross operating margin | €-8k | €78k | |
| Staff costs | €6k | €21k |
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
€-20k
-
far below sector median
€-103k
-
far below sector median
€-50k
-
far below sector median
€1.17M
+101.2%
far above sector median
€-61k
-
far below sector median
€-232k
-72.7%
far below sector median
€6k
-
-77% vs sector
€441
-91.4%
-99% vs sector
€1.23M
+128.4%
far above sector median
€237k
+69.2%
+239% vs sector
€992k
+149.2%
far above sector median
0.02
-46.0%
-99% vs sector
0.02
-46.0%
-99% vs sector
-5.2%
-
far below sector median
-20.21
-
far below sector median
169.5%
+482.8%
far above sector median
-8.8%
-
far below sector median
-0.69
-
far below sector median
Figures by fiscal year
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €-20k |
| Net profit | €-103k |
| Cash flow | €-50k |
| Staff costs | €6k |
| Income taxes | €441 |
| Dividends | - |
| Total assets | €1.17M |
| Equity | €-61k |
| Debt | €1.23M |
| of which ≤ 1y | €237k |
| of which > 1y | €992k |
| Working capital | €-232k |
| Employees (FTE) | - |
Ratios (computed)
| 2024 | |
|---|---|
| Current ratio | 0.02 |
| Quick ratio | 0.02 |
| Working capital ratio | -19.8% |
| Solvency | -5.2% |
| Debt / equity | -20.21 |
| Long-term debt ratio | -16.31 |
| Interest coverage | -0.69 |
| Gross margin | - |
| Net margin | - |
| ROA | -8.8% |
| ROE | 169.5% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Balance-sheet composition 2024
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €1.17M |
| Fixed assets | 21/28 | €1.16M |
| Intangible fixed assets | 21 | €86k |
| Tangible fixed assets | 22/27 | €1.07M |
| Financial fixed assets | 28 | €5k |
| Current assets | 29/58 | €6k |
| Cash & bank | 54/58 | €205 |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €1.17M |
| Equity | 10/15 | €-61k |
| Contributions / capital | 10/11 | €30k |
| Accumulated profits (losses) | 14 | €-91k |
| Amounts payable | 17/49 | €1.23M |
| Amounts payable after one year | 17 | €992k |
| Amounts payable within one year | 42/48 | €237k |
| Trade debts payable within one year | 44 | €37k |
| Income statement | ||
| Gross operating margin | 9900 | €-8k |
| Operating result | 9901 | €-73k |
| Financial charges | 65 | €30k |
| Result before taxes | 9903 | €-103k |
| Income taxes | 67/77 | €441 |
| Net result for the period | 9904 | €-103k |
| Result to be appropriated | 9905 | €-103k |
You're seeing the latest fiscal year only. Unlock 1 prior year (figures + ratios) with a paid plan.
See plans →
Ratios computed by Checked.
Health barometer
FY 2024 · computed7
/ 100
Critical
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →Computed by Checked from NBB filings and Belgian State Gazette signals. Indicative, not credit advice.
Structure & network
Locations & real estate
Establishment units
1 locationAREDENTAL
since 20222.339.998.504
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels2
Ground area1,234 m²
Buildings2
Building footprint1,179 m²
Volume (LiDAR)21,886 m³
Tallest building28.8 m · ±8 fl.
Real-estate footprint
Source: CBE × cadastre · address linkingParcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
Brussels
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21905C0090/00X003 | Brussels | 1,104 m² | 1 · 1,107 m² | 28.8 m · 8 fl. |
| 21906D0072/00L011 | Brussels | 130 m² | 1 · 72 m² | 18.4 m · 5 fl. |
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Publications
Lifecycle & Insolvency Signals
No insolvency signals in the Belgian State Gazette
Belgisch Staatsblad · acts
2 acts Address history · 1
10-02-2026
v3.2
All acts · 2
updated 6 months ago
2026
10-02-2026 Registered office moved from Uccle to Schaerbeek
- Avenue de Frè 267, 1180 Uccle → Chaussée de Louvain 550, 1030 Schaerbeek
Summary:
v3.2
2022
29-12-2022 Incorporation of a new SRL
Summary:
oprichting
Analysis
Snowflake analysis
financial profile on 5 axes53
/ 100
Mixed profile: strong on profitability, weaker on health.
Health
7
Profitability
100
Solvency
33
Growth
32
Stability
94
Ask AI about this company
Checked AISoon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.
TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soonAI due-diligence brief
Checked AIGenerate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works
Credit advice
verdict per customer and amountSimilar
Similar companies
Same sector, nearest firstCompany registry
Company registry (CBE)
Crossroads BankActivities
Tandartspraktijken86230Activiteiten van tandartspraktijken86230
Primary activity highlighted.
Names & trade names
| Legal nameFR | AREDENTAL |
Registered office
Leuvensesteenweg 550 bus 42-4
1030 Schaarbeek, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.